Condition: Pancreatic Ductal Adenocarcinoma (PDAC) · Sponsor: SOFIE
This is a multi-site, open-label, non-randomized, single dose study to assess the clinical utility of \[¹⁸F\]FAPI-74 PET/CT in the detection of metastatic disease in individuals with pathologically confirmed pancreatic ductal adenocarcinoma. Following screening, using a standardized administration protocol and dose, participants will undergo \[¹⁸F\]FAPI-74 PET/CT screening. SOC procedures and interventions will be captured during 3 months +/-14 days post injection. The primary objective is to evaluate the sensitivity and specificity of such \[¹⁸F\]FAPI-74 PET/CT using a composite SOT panel. The maximum expected duration of the trial is approximately 24 months from first patient screening to last patient SOC follow up. The participants will be followed-up for safety for 24 to 72 hours after the dose of \[¹⁸F\]FAPI-74 PET/CT.
This description comes directly from the study's public registry record.
Alex Osipova · 1-800-753-5368 · Alex.osipova@sofie.com
Bridget Adams · 1-800-753-5368 · bridget.adams@sofie.com
Always discuss trial participation with your own doctor first.
| Helios CR Inc./RadNet | Cerritos, California, United States | Recruiting |
| City of Hope National Cancer Center | Duarte, California, United States | Recruiting |
| Hoag Memorial Hospital | Irvine, California, United States | Recruiting |
| UCLA | Los Angeles, California, United States | Recruiting |
| Stanford University | Stanford, California, United States | Recruiting |
| Moffit Cancer Center | Tampa, Florida, United States | Recruiting |
| Indiana University Health University Hospital | Indianapolis, Indiana, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| UMass/Shields | Worcester, Massachusetts, United States | Recruiting |
| Mayo Clinic Rochester | Rochester, Minnesota, United States | Recruiting |
| Icahn School of Medicine at Mount Sinai | New York, New York, United States | Not Yet Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07217717